Publication | Open Access

HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial

Breast OncologyNeoadjuvant TrastuzumabMedicinePathologyBreast CancerPerelisa TrialCancer TreatmentOncologyRadiation OncologyHer2dx Genomic TestEndocrine-related Cancer